Cargando…
局部晚期非小细胞肺癌同步放化疗中紫杉醇两种用法的多中心、随机对照研究
BACKGROUND AND OBJECTIVE: Although the guidelines of the National Comprehensive Cancer Network of USA recommend that the standard therapy for locally advanced non-small cell lung cancer (LANSCLC) is concurrent chemoradiotherapy. There is ongoing controversy about the treatment regimen which combines...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999657/ https://www.ncbi.nlm.nih.gov/pubmed/21426664 http://dx.doi.org/10.3779/j.issn.1009-3419.2011.03.08 |
Ejemplares similares
-
紫杉醇脂质体诱导加同期放化疗与序贯放化疗治疗局部晚期非小细胞肺癌的随机对照研究
Publicado: (2011) -
紫杉醇脂质体单药与紫杉醇脂质体联合奥沙利铂一线治疗老年晚期非小细胞肺癌的随机对照研究
Publicado: (2012) -
紫杉醇联合卡铂三周方案同步胸部放疗治疗不宜手术的局部晚期非小细胞肺癌疗效和安全性研究:一项来自单中心的回顾性研究
Publicado: (2016) -
紫杉醇脂质体联合顺铂方案一线治疗晚期非小细胞肺癌的临床随机对照研究
Publicado: (2012) -
同步推量调强放疗在局部晚期非小细胞肺癌中的应用
Publicado: (2019)